The purpose of the study is to determine if a specific blood protein, S-100B, can help predict who will have a traumatic abnormality on head CT scan after a concussion. We will compare the levels of this protein in the subject's blood to the initial head CT scan and to how the subject is feeling one month after injury. We hope that the information we collect in this trial will help us determine who needs a head CT scan after a concussion and who may be more likely to have trouble recovering from a concussion.
The primary objective of this study is to determine the ability of a serum S-100B to predict traumatic abnormalities on brain CT scan after mild traumatic brain injury (mild TBI). The secondary objective is to determine the relationship between initial S-100B levels and cognitive outcome at one month.
Study Type
OBSERVATIONAL
Enrollment
1,252
Albany Medical College
Albany, New York, United States
Erie County Medical Center
Buffalo, New York, United States
Bassett Healthcare
Cooperstown, New York, United States
University of Rochester Medical Center
Rochester, New York, United States
Head CT scan
Time frame: At time of injury in ED
Post concussive symptoms
Time frame: One month after injury
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
SUNY Upstate Medical Center at Syracuse
Syracuse, New York, United States
Guthrie
Sayre, Pennsylvania, United States